From March 12 to 14, BIOCHINA 2026, the 11th Ebio Biotech Industry Conference, a highly anticipated event in the sector, took place at Suzhou International Expo Center. This grand gathering facilitates exchanges and collaboration across the entire biomedicine industrial chain. It featured over 900 speakers from government bodies, clinical institutions, enterprises, research institutes and investment communities, drew more than 400 exhibitors and over 30,000 attendees, with participants from more than 40 overseas countries and regions. As a CDMO player specializing in biomacromolecules, Baino Chuangrui (Wenzhou) Biotechnology Co., Ltd. (hereinafter referred to as Chuangrui Bio) delivered an impressive performance at Booth F3B06.

Technical Highlights | Specialized Production Lines Attract Wide Attention
At this exhibition, Chuangrui Bio presented not only end-to-end solutions covering R&D through manufacturing for recombinant protein and antibody drugs, but also practical approaches to address prevailing industry pain points. The BFS sterile eye drop/inhalant production line and sterile topical gel formulation production line showcased as key exhibits stood out at the booth owing to their scarcity within the biomacromolecular formulation segment.

Questions such as “How to improve the stability of active proteins in liquid formulations?” and “How to realize the industrial production of ophthalmic drugs with stringent sterility requirements?” are frequently encountered challenges in the industry. Supported by a robust sterile quality control system, Chuangrui Bio provides one-stop solutions spanning formulation development to large-scale manufacturing, offering more flexible pathways for the innovative translation of recombinant protein and antibody therapeutics.

Memorable Moments • Constant Foot Traffic at the Booth
Over the three-day exhibition, Chuangrui Bio’s booth maintained a vibrant atmosphere for exchanges. The technical team was fully engaged, introducing service offerings and responding to a stream of follow-up questions from visitors. Topics ranged from yield challenges during process scaling to applicable scenarios of the BFS production line, with sparks of inspiration generated through every discussion.

Meanwhile, the carefully arranged lucky draw brought a relaxed and lively vibe to the booth. Attractive and practical custom gifts including power banks and phone stands drew many attendees to join the activity, creating many pleasant moments alongside technical communications.

Keep Moving Forward • Looking Forward to Our Next Meeting
The exhibition has concluded, yet conversations on innovation and translation are just getting started. The preliminary consensus reached at the booth and cooperative inspirations sparked during communications will fuel Chuangrui Bio’s continued progress. Going forward, we will keep leveraging our professional CDMO platform and join hands with global partners to bring more biomacromolecular drugs from the laboratory to clinics, and from China to the world.